Human Anti-Chikungunya Virus IgM ELISA Kit (ab177848)
Key features and details
- Sample type: Cit plasma, Hep Plasma, Serum
- Detection method: Colorimetric
- Assay type: Sandwich (qualitative)
- Reacts with: Human
Overview
-
Product name
Human Anti-Chikungunya Virus IgM ELISA Kit -
Detection method
Colorimetric -
Precision
Intra-assay Sample n Mean SD CV% Low + serum 23 4.8% High + serum 24 3.4% Inter-assay Sample n Mean SD CV% Low + serum 3 7.3% High + serum 3 2.9% -
Sample type
Serum, Hep Plasma, Cit plasma -
Assay type
Sandwich (qualitative) -
Assay duration
Multiple steps standard assay -
Species reactivity
Reacts with: Human -
Product overview
Abcam’s anti-Chikungunya Virus IgM Human in vitro ELISA (Enzyme-Linked Immunosorbent Assay) kit is designed for the accurate qualitative measurement of IgM class antibodies against Chikungunya Virus in Human serum and plasma.
A 96-well plate has been precoated with anti-Human antibodies to bind to corresponding antibodies of the sample. Controls or test samples are added to the wells and incubated. Following washing, the Chikungunya Virus antigen is added to the wells and incubated. The wells are then washed as before and the biotinylated Chikungunya Virus antibodies are added to each well followed by incubation. After a last wash step, the streptavidin peroxidase (SP) conjugate which binds to the biotinylated Chikungunya Virus-specific antibodies is added to the wells. TMB is then catalyzed by the SP to produce a blue color product that changes to yellow after adding an acidic stop solution. The density of yellow coloration is directly proportional to the amount of Chikungunya Virus IgM sample captured in plate.
-
Platform
Microplate
Properties
-
Storage instructions
Store at +4°C. Please refer to protocols. -
Components Identifier 1 x 96 tests 20X Washing Solution White cap 1 x 50ml Anti-Human (IgM) Coated Microplate (12 x 8 wells) 1 unit Chikungunya IgM Negative Control 1 x 1.5ml Chikungunya Virus antigen Solution 1 (Lyophilized) 6 vials Chikungunya Virus biotinylated antibody Solution 2 1 x 6ml Chikungunya Virus IgM Cut-off Control 1 x 2ml Chikungunya Virus IgM Positive Control 1 x 1.5ml Cover Foil 1 unit Sample Diluent 1 x 100ml Stop Solution red cap 1 x 15ml Streptavidin Conjugate 1 x 6ml Strip holder 1 unit TMB Substrate Solution Yellow cap 1 x 15ml -
Research areas
Datasheets and documents
-
SDS download
-
Datasheet download
References (11)
ab177848 has been referenced in 11 publications.
- Rueda JC et al. Can presence of HLA type I and II alleles be associated with clinical spectrum of CHIKV infection? Transbound Emerg Dis 69:e895-e905 (2022). PubMed: 34752688
- Luvai EAC et al. Evidence of Chikungunya virus seroprevalence in Myanmar among dengue-suspected patients and healthy volunteers in 2013, 2015, and 2018. PLoS Negl Trop Dis 15:e0009961 (2021). PubMed: 34851949
- Castellanos JE et al. Dengue-chikungunya coinfection outbreak in children from Cali, Colombia in 2018-2019. Int J Infect Dis 102:97-102 (2021). PubMed: 33075526
- Nayak K et al. Antibody response patterns in chikungunya febrile phase predict protection versus progression to chronic arthritis. JCI Insight 5:N/A (2020). PubMed: 32155134
- Rueda JC et al. Demographic and clinical characteristics of chikungunya patients from six Colombian cities, 2014-2015. Emerg Microbes Infect 8:1490-1500 (2019). PubMed: 31631794